Ogni antibiotico è efficace in relazione a un determinato gruppo di microrganismi comprare doxycycline senza ricettain caso di infezioni oculari vengono scelte gocce ed unguenti.
04HQ3972 5/09 Blue Cross and Blue Shield of Louisiana incorporated as Louisiana Health Service & Indemnity Company
A SMART STEP TO BETTER HEALTH
Make generics your first step to better health. Generics are "copycats" of brand-name drugs and offer a better value. They're safe and effective and cost less than brand-name drugs. And most importantly — they're approved by the U.S. Food and Drug Administration (FDA).
LEAD WITH GENERICS
Lead with Generics
, our new prescription step therapy program, promotes the use of generic drugs as your first step to treat your condition. The program is designed to help you get effective treatment while keeping your prescription drugs affordable. Lead with Generics
requires you to try a generic option or similar alternative medication (in certain drug classes) before you use a brand-name drug.
The drug classes that require the use of generics first are those designed to treat chronic conditions such as arthritis, depression and high blood pressure.
The following categories of
prescription drugs are included in our
Lead with Generics program. Some
examples of Step 2 brand-name drugs
and their generic options are also
included in each category:
Example Generic Options
Example Brand-Name Drugs
(STEP 1 DRUGS)
(STEP 2 DRUGS)
Altace® (tablet), Atacand®,
Benazepril, Enalapril, Lisinopril,
Avapro®, Benicar®, Cozaar,
Quinapril, Ramipril, Trandolapril
Diovan®, Micardis®, Tekturna®,
Atacand HCT®, Avalide®, Azor®,
Benicar HCT®, Diovan HCT®,
Benazepril/HCTZ, Lisinopril/HCTZ, Exforge®, Exforge HCT®, Hyzaar®,
Micardis® HCT, Tekturna HCT®,
Altoprev®, Advicor®, Caduet®
(10mg and 20mg), Crestor®
(5 mg), Lescol®, Lescol XL®,
Lipitor® (10 mg, 20 mg), Simcor®,
Cymbalta®, Effexor XR®,
Lexapro®, Luvox CR®, Pexeva®,
Pristiq®, Prozac Weekly®,
Aciphex®, Kapidex®, Nexium®,
Meloxicam, Naproxen, Naproxen
Astelin®, Astepro®, Beconase
AQ®, Nasacort AQ®, Nasonex®,
Omnaris®, Patanase®, Rhinocort
Clarinex-D®, Singulair®, Xyzal®
Ambien CR®, Edluar®, Lunesta®,
With the generic drug, you pay the lowest out-of-pocket costs and get the best value.
If you choose a brand-name drug in the categories listed in our Lead with Generics
program without first trying the generic option, you will be responsible for the full cost of the drug. If you try a generic option and it doesn't work for you, you may be able to take a brand-name drug without penalty.
Here's How It Works
The next time your doctor writes you a prescription in one of the drug classes identified for our program:
Ask if a generic option (Step 1) drug is right for you.
If you've already tried a generic option, or if your doctor decides one of these generics is not right for you, your physician may call 1.800.842.2015 to request an authorization for a brand-name (Step 2) drug.
If your physician's request for a brand-name drug does not meet the necessary criteria to start a brand-name drug (without you first trying a Step 1 drug), or if you simply choose a brand-name drug from our Lead with Generics
program without first trying a generic option, the brand-name drug will not be covered under your benefits
If You Are Already Using a Brand-Name (Step 2) Drug
If you are already taking a brand-name drug identified in our Lead with Generics
program when the program is first implemented on your benefit plan, you are not required to change to a generic option. However, you are required to try a generic option for any new drug prescribed after the start of the program, if your treatment calls for Step 2 drugs included in our Lead with Generics
Why Lead with Generics?
This program is part of our long-term commitment to keeping the cost of healthcare down and our members' premiums as low as possible. Our Lead with Generics
program is designed to save you money in two ways. First, in every benefit plan we offer, Step 1 generic drugs cost you less than Step 2 brand-name drugs. Second, using generic drugs helps to reduce overal costs and keep premiums down.
To learn more or ask questions about our new Lead with Generics
To send our Customer Service
Baton Rouge: 225.293.0625
Department a secure e-mail
message, please go to our
website at www.bcbsla.com,
5525 Reitz Avenue
click Contact Us, then choose
Baton Rouge, Louisiana 70809-3802
Online Customer Inquiry Form.
What is the Lead with Generics program?
Lead with Generics
is a new prescription step therapy program that requires
members to try a lower-cost generic option first when filling a new prescription
(in certain drug classes) before they try a higher-cost brand-name drug.
Generic drugs are considered Step 1 in the program. Brand-name drugs are
considered Step 2.
Why is Blue Cross starting this program?
We want to make sure that all of our members are getting the best value for
their pharmacy dollars. Generics are typically less expensive than brand-name
drugs and can effectively treat your condition. The average brand-name drug
often costs nearly five times more than a generic drug. A generic option will
typically cost much less, regardless of your insurance benefit plan.
I have been taking a brand-name drug included in the Lead with Generics
program, and it is working well for me. Do I really need to switch and try
No. If you are already taking a brand-name drug included in the Lead with
program, you will not be required to change to the generic option.
It's only when you start taking a newly prescribed drug in one of the classes
listed in this brochure that you will be required to try a lower-cost generic
option (Step 1) before a higher-cost brand-name (Step 2) drug.
My doctor has prescribed a brand-name drug that he thinks will work better
for me than a generic drug. Am I still required to try a generic option?
If your doctor decides one of the Step 1 drugs isn't right for you, then the
doctor can call us at 1.800.842.2015 for an authorization for a Step 2 drug. If
your physician's request for a Step 2 drug does not meet the necessary criteria
to start a Step 2 drug (without you first trying a Step 1 drug), or if you choose
a Step 2 brand-name drug included in the Lead with Generics
first trying a Step 1 generic option, it will not be covered under your benefits,
and you will be responsible for the full cost of the drug
Are generics really as effective and safe as brand-name drugs?
Yes, generic drugs are safe and effective. Generic drugs are approved by the
U.S. Food and Drug Administration (FDA), just like brand-name drugs. This
means that generics must undergo strict testing to ensure their effectiveness.
What should I do if I bring a new brand-name prescription from my doctor to
the pharmacy to fill, and the pharmacy says that it can't be filled because I am
required to try a generic option as part of the Lead with Generics program?
If your prescription is denied at the pharmacy, please have the pharmacist
check with your doctor and request that he prescribe a generic option (Step
1 drug). If your doctor does not believe a generic option will work for you,
the pharmacist may ask your doctor to call 1.800.842.2015 and request an
approval so that the brand-name drug may be covered by your plan if certain
criteria are met. Pharmacists will be educated on how to provide you with a
five-day supply of the brand-name drug if your prescription is denied and your
doctor can't quickly be reached to prescribe a generic option.
Are the generic options included in Step 1 of the Lead with Generics program
the same or equivalent to the Step 2 brand-name drugs?
Generic equivalents and generic options work similarly to brand-name drugs. A
generic equivalent is made with the same active ingredient as the brand-name
drug. The chemicals in a generic option may differ slightly from the brand-
name drug or its generic equivalent. But generic options are used to treat the
same conditions — and most importantly, generic options are determined to be
safe and effective by the FDA.
My doctor just prescribed Crestor® for me, which is one of the cholesterol
drugs listed in the Lead with Generics program. He prescribed a high dosage –
Crestor® 20 mg – but I notice Crestor® 20 mg is not included as an example
of a strength that will be included in the Lead with Generics program.
What does this mean?
In the case of certain high-potency cholesterol medications (Caduet®,
Crestor®, Lipitor®, Vytorin®), we are only requiring that members try generic
alternatives for the lower strengths. Higher strengths of certain cholesterol
medications are not included in the program because there are no appropriate
generic options currently available for the higher strengths.
JOURNAL OF PETROLOGY Occurrence and Origin of Andalusite inPeraluminous Felsic Igneous Rocks D. BARRIE CLARKE1*, MICHAEL DORAIS2, BERNARD BARBARIN3,DAN BARKER4, BERNARDO CESARE5, GEOFFREY CLARKE6,MOHAMED EL BAGHDADI7, SASKIA ERDMANN1, HANS-JU ¨ RSTER8, MARIO GAETA9, BA¨RBEL GOTTESMANN8, REBECCA A. JAMIESON1, DANIEL J. KONTAK10, FRIEDRICHKOLLER11, CARLOS LEAL GOMES12, DAVID LONDON13,GEORGE B. MORGAN VI13, LUIS J. P. F. NEVES14, DAVID R. M.PATTISON15, ALCIDES J. S. C. PEREIRA14, MICHEL PICHAVANT16,CARLOS W. RAPELA17, AXEL D. RENNO18, SIMON RICHARDS19,MALCOLM ROBERTS20, ALESSANDRO ROTTURA21, JULIOSAAVEDRA22, ALCIDES NOBREGA SIAL23, ALEJANDRO J.TOSELLI24, JOSE M. UGIDOS25, PAVEL UHER26, CARLOSVILLASECA27, DARIO VISONA
Methotrexat Therapie bei rheumatologischen Erkrankungen- ein Update OA Dr. Edmund Cauza Aminopterin, ein Vorläufer des Methotrexats (MTX), wurde erstmals in den frühen 50er Jahren zur Behandlung der rheumatoiden Arthritis (RA) als auch Psoriasis Arthritis (PsA) eingesetzt (15). Kortikosteroide und in einem gewissen Ausmaß Cyclophosphamid (CPH)